178 related articles for article (PubMed ID: 27393304)
21. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
Arita K; Shimizu T; Hashimoto H; Hidaka Y; Yamada M; Sato M
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5291-6. PubMed ID: 16567635
[TBL] [Abstract][Full Text] [Related]
22. Structure and mechanism of a bacterial host-protein citrullinating virulence factor, Porphyromonas gingivalis peptidylarginine deiminase.
Goulas T; Mizgalska D; Garcia-Ferrer I; Kantyka T; Guevara T; Szmigielski B; Sroka A; Millán C; Usón I; Veillard F; Potempa B; Mydel P; Solà M; Potempa J; Gomis-Rüth FX
Sci Rep; 2015 Jul; 5():11969. PubMed ID: 26132828
[TBL] [Abstract][Full Text] [Related]
23. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
24. An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes.
Alghamdi M; Al Ghamdi KA; Khan RH; Uversky VN; Redwan EM
Cell Mol Life Sci; 2019 Dec; 76(23):4635-4662. PubMed ID: 31342121
[TBL] [Abstract][Full Text] [Related]
25. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanism.
Dreyton CJ; Knuckley B; Jones JE; Lewallen DM; Thompson PR
Biochemistry; 2014 Jul; 53(27):4426-33. PubMed ID: 24989433
[TBL] [Abstract][Full Text] [Related]
27. Autocitrullination and Changes in the Activity of Peptidylarginine Deiminase 3 Induced by High Ca
Sawata M; Shima H; Murayama K; Matsui T; Igarashi K; Funabashi K; Ite K; Kizawa K; Takahara H; Unno M
ACS Omega; 2022 Aug; 7(32):28378-28387. PubMed ID: 35990454
[TBL] [Abstract][Full Text] [Related]
28. Functional role of dimerization of human peptidylarginine deiminase 4 (PAD4).
Liu YL; Chiang YH; Liu GY; Hung HC
PLoS One; 2011; 6(6):e21314. PubMed ID: 21731701
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
[TBL] [Abstract][Full Text] [Related]
30. Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?
Padhy DS; Palit P; Ikbal AMA; Das N; Roy DK; Banerjee S
Inflammopharmacology; 2023 Apr; 31(2):731-744. PubMed ID: 36806957
[TBL] [Abstract][Full Text] [Related]
31. Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes.
Bello AM; Wasilewski E; Wei L; Moscarello MA; Kotra LP
ACS Med Chem Lett; 2013 Feb; 4(2):249-53. PubMed ID: 24900657
[TBL] [Abstract][Full Text] [Related]
32. Deimination is regulated at multiple levels including auto-deimination of peptidylarginine deiminases.
Méchin MC; Coudane F; Adoue V; Arnaud J; Duplan H; Charveron M; Schmitt AM; Takahara H; Serre G; Simon M
Cell Mol Life Sci; 2010 May; 67(9):1491-503. PubMed ID: 20111885
[TBL] [Abstract][Full Text] [Related]
33. Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4.
Stensland ME; Pollmann S; Molberg Ø; Sollid LM; Fleckenstein B
Biol Chem; 2009 Feb; 390(2):99-107. PubMed ID: 19040354
[TBL] [Abstract][Full Text] [Related]
34. Refined crystal structures of human Ca(2+)/Zn(2+)-binding S100A3 protein characterized by two disulfide bridges.
Unno M; Kawasaki T; Takahara H; Heizmann CW; Kizawa K
J Mol Biol; 2011 May; 408(3):477-90. PubMed ID: 21377473
[TBL] [Abstract][Full Text] [Related]
35. Recognition of the N-terminal histone H2A and H3 peptides by peptidylarginine deiminase IV.
Saiki M; Watase M; Matsubayashi H; Hidaka Y
Protein Pept Lett; 2009; 16(9):1012-6. PubMed ID: 19508226
[TBL] [Abstract][Full Text] [Related]
36. Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase-AIF pathway.
U KP; Subramanian V; Nicholas AP; Thompson PR; Ferretti P
Biochim Biophys Acta; 2014 Jun; 1843(6):1162-71. PubMed ID: 24607566
[TBL] [Abstract][Full Text] [Related]
37. Expression pattern of peptidylarginine deiminase in rat and human Schwann cells.
Keilhoff G; Prell T; Langnaese K; Mawrin C; Simon M; Fansa H; Nicholas AP
Dev Neurobiol; 2008 Jan; 68(1):101-14. PubMed ID: 17948239
[TBL] [Abstract][Full Text] [Related]
38. Phytoalexin-deficient mutants of Arabidopsis reveal that PAD4 encodes a regulatory factor and that four PAD genes contribute to downy mildew resistance.
Glazebrook J; Zook M; Mert F; Kagan I; Rogers EE; Crute IR; Holub EB; Hammerschmidt R; Ausubel FM
Genetics; 1997 May; 146(1):381-92. PubMed ID: 9136026
[TBL] [Abstract][Full Text] [Related]
39. Structural and biochemical analyses of the human PAD4 variant encoded by a functional haplotype gene.
Horikoshi N; Tachiwana H; Saito K; Osakabe A; Sato M; Yamada M; Akashi S; Nishimura Y; Kagawa W; Kurumizaka H
Acta Crystallogr D Biol Crystallogr; 2011 Feb; 67(Pt 2):112-8. PubMed ID: 21245532
[TBL] [Abstract][Full Text] [Related]
40. Induction of peptidylarginine deiminase 2 and 3 by dibutyryl cAMP via cAMP-PKA signaling in human astrocytoma U-251MG cells.
Masutomi H; Kawashima S; Kondo Y; Uchida Y; Jang B; Choi EK; Kim YS; Shimokado K; Ishigami A
J Neurosci Res; 2017 Jul; 95(7):1503-1512. PubMed ID: 27704563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
